{"id":"https://openalex.org/W771481671","doi":null,"title":"Enhanced Topical Delivery of a Small Molecule Receptor Tyrosine Kinase Inhibitor (RTKi) via Mucosal-Penetrating Particle Technology","display_name":"Enhanced Topical Delivery of a Small Molecule Receptor Tyrosine Kinase Inhibitor (RTKi) via Mucosal-Penetrating Particle Technology","publication_year":2013,"publication_date":"2013-06-16","ids":{"openalex":"https://openalex.org/W771481671","mag":"771481671"},"language":"en","primary_location":{"id":"mag:771481671","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2145672","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053062539","display_name":"Lisa R. Schopf","orcid":"https://orcid.org/0000-0002-9990-3490","observed_orcids":["https://orcid.org/0000-0002-9990-3490"]},"institutions":[{"id":"https://openalex.org/I4210088201","display_name":"Kala Pharmaceuticals (United States)","ror":"https://ror.org/007bef738","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Schopf","raw_affiliation_strings":["R&D, Kala Pharmaceuticals, Waltham, MA"],"raw_orcid":"https://orcid.org/0000-0002-9990-3490","affiliations":[{"raw_affiliation_string":"R&D, Kala Pharmaceuticals, Waltham, MA","institution_ids":["https://openalex.org/I4210088201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110652468","display_name":"Elizabeth Enlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088201","display_name":"Kala Pharmaceuticals (United States)","ror":"https://ror.org/007bef738","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Enlow","raw_affiliation_strings":["R&D, Kala Pharmaceuticals, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D, Kala Pharmaceuticals, Waltham, MA","institution_ids":["https://openalex.org/I4210088201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103916998","display_name":"Alexey Popov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088201","display_name":"Kala Pharmaceuticals (United States)","ror":"https://ror.org/007bef738","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexey Popov","raw_affiliation_strings":["R&D, Kala Pharmaceuticals, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D, Kala Pharmaceuticals, Waltham, MA","institution_ids":["https://openalex.org/I4210088201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050016548","display_name":"James L. Bourassa","orcid":"https://orcid.org/0009-0008-0155-0051","observed_orcids":["https://orcid.org/0009-0008-0155-0051"]},"institutions":[{"id":"https://openalex.org/I4210088201","display_name":"Kala Pharmaceuticals (United States)","ror":"https://ror.org/007bef738","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Bourassa","raw_affiliation_strings":["R&D, Kala Pharmaceuticals, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D, Kala Pharmaceuticals, Waltham, MA","institution_ids":["https://openalex.org/I4210088201"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100729956","display_name":"Hongming Chen","orcid":"https://orcid.org/0000-0002-8065-8333","observed_orcids":["https://orcid.org/0000-0002-8065-8333","https://orcid.org/0000-0002-4052-8155","https://orcid.org/0009-0000-8187-4663"]},"institutions":[{"id":"https://openalex.org/I4210088201","display_name":"Kala Pharmaceuticals (United States)","ror":"https://ror.org/007bef738","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongming Chen","raw_affiliation_strings":["R&D, Kala Pharmaceuticals, Waltham, MA"],"raw_orcid":"https://orcid.org/0000-0002-8065-8333","affiliations":[{"raw_affiliation_string":"R&D, Kala Pharmaceuticals, Waltham, MA","institution_ids":["https://openalex.org/I4210088201"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210088201"],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":null,"fwci":0.2363,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.47776959,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"54","issue":"15","first_page":"1087","last_page":"1087"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.9520000219345093},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.8679999709129333},{"id":"https://openalex.org/keywords/small-molecule-drugs","display_name":"small molecule drugs","score":0.6359999775886536},{"id":"https://openalex.org/keywords/ocular-surface","display_name":"ocular surface","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5141296982765198},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5029205679893494},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.46678316593170166},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43811506032943726},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3618660569190979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19926610589027405},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12138435244560242},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07064837217330933},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:771481671","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2145672","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2992014943","https://openalex.org/W2994098672","https://openalex.org/W1868001086","https://openalex.org/W599181181","https://openalex.org/W2574517999","https://openalex.org/W982155252","https://openalex.org/W2739433882","https://openalex.org/W2992411218","https://openalex.org/W2745841734","https://openalex.org/W978177268"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}